NIFTY
54.90  0.50%
 10961.85
S&P BSE SENSEX
192.35  0.53%
 36578.96
Biocon Ltd.
NSE : BIOCON BSE : 532523 ISIN code : INE376G01013
on 21-Jan-2019
NSE
10.95    1.68%
Rs. 663.00
 
Days Low
Rs. 653.7
Days High
Rs. 670.5

Open Rs. 654
 
52 week Low
Rs. 543.8
52 week High
Rs.718.35
 
 
Bid :                 663.20 (1783)
Offer :        0.00 (0)
BSE
Rs.663.20
12.1    1.86%
on 21-Jan-2019
BSE
12.1    1.86%
Rs. 663.20
 
Days Low
Rs. 654.3
Days High
Rs. 671.3

Open Rs. 654.8
 
52 week Low
Rs. 543.3
52 week High
Rs.718
 
 
Bid :                 663.20 (1783)
Offer :        0.00 (0)
NSE
Rs.663.00
10.95    1.68%
 
 
Last Price (Rs.)  663.20 Value  86505553.00
Net Change (Rs.)  12.10 Best Buy  663.20
Volume  130450 Best Sell  0.00
Prev.Close (Rs.)  651.10 Best Quantity  1783
Open (Rs.)  654.00 Sell Quantity  0
High (Rs.)  670.50 52-Week High (Rs.)  718.35
Low (Rs.)  653.70 52-Week Low (Rs.)  543.80
Face Value (Rs.)  5 Market Cap.(Rs/ Mn)  397920.00
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital3000.00 1000.00 1000.00 
Share Capital3000.00 1000.00 1000.00 
Share Capital3000.00 1000.00 1000.00 
Share Capital3000.00 1000.00 1000.00 
Share Capital3000.00 1000.00 1000.00 
Currents Investments4538.00 5247.00 5983.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 398.35 955772 77.62 0.00 0.50
Aurobindo Pharma 776.00 454664 180.71 25.08 0.32
Dr. Reddys Lab 2601.85 432065 725.78 76.19 0.77
Piramal Enterprises 2281.70 418916 1080.13 79.33 1.10
Cipla 510.80 411535 183.33 28.00 0.59
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Sep 2018Jun 2018Mar 2018
Net Sales7089.006722.006481.00
Operating Profit1476.001226.001187.00
PBDT1811.002866.001189.00
Net Profit1198.002297.00719.00
More> 
 
Company News
12/19/2018 12:00:00 AM
Biosimilar Trastuzumab Co-Developed By Biocon Receives Approval In Th...
12/19/2018 12:00:00 AM
Biocon, Mylan’s joint product Ogivri gets approval in EU
12/18/2018 12:00:00 AM
Biocon trades higher on the bourses
More>
 
Ratios
   Earnings Per Share (Rs)3.98 
   Book NAV/Share(Rs)111.47 
   PAT Margin (%)9.83 
   Asset Turnover(x)0.32 
   PER(x)149.48 
   Yield(%)0.17 
   EV/Core EBITDA(x)80.35 
   M Cap / Sales14.74 
   Net Sales Growth(%)-6.52 
   PAT Growth(%)-54.07 
   Total Debt/Equity(x)0.02 
   Current Ratio(x)2.47 
   Quick Ratio(x)1.80 
   Total Debt/Mcap(x)0.00 
More>